For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251202:nRSB9261Ja&default-theme=true
RNS Number : 9261J Praetura Growth VCT Plc 02 December 2025
Praetura Growth VCT plc (the "Company")
Publication of Prospectus
2 December 2025
LEI: 9845004ZDC57AB064B97
A prospectus relating to an offer for subscription of up to £10 million of
ordinary shares of £0.01 each, together with an over-allotment facility for
up to a further £10 million of ordinary shares (the "Offer"), has today been
issued by the Company (the "Prospectus").
The Offer will open on 2 December 2025 and is expected to close no later than
3.00 p.m. on 1 April 2026 for shares to be allotted in the 2025/26 tax year
and, no later than 3.00 p.m. on 27 November 2026 for shares to be allotted in
the 2026/27 tax year.
Pursuant to an offer agreement dated 2 December 2025 relating to the Offer
between, among others, the Company and Praetura Ventures Limited ("Praetura
Ventures"), Praetura Ventures will receive a fee of up to 5% of the
application amounts received by the Company under the Offer, subject to an
aggregate cap of £321,403. Praetura Ventures, as the investment manager of
the Company, is a related party of the Company, and the payment of such a fee
by the Company to Praetura Ventures is a relevant related party transaction of
an adequate size for UK Listing Rule 8.2.1R to apply. The Board considers this
transaction fair and reasonable as far as the shareholders of the Company are
concerned having been so advised by the Company's sponsor, Howard Kennedy
Corporate Services LLP.
Investment Strategy and Manager Update The Company's investment objective is
to achieve long-term capital appreciation by investing in a diversified
portfolio of growth companies. The investment policy is focused on scalable
businesses predominantly situated in, or servicing, regions of the UK outside
of London and the South East of England.
The Company's Investment Manager is Praetura Ventures Limited. As detailed in
the Prospectus, Praetura Ventures has recently combined with Par Equity to
form the PXN Group. This combination creates a significant regional venture
capital platform, managing approximately £660 million in assets (as at 31
July 2025). The Board believes this provides the Company with enhanced access
to deal flow, resources, and co-investment opportunities across the North of
England, Scotland, and Northern Ireland.
Portfolio Momentum Since its launch, the Company has deployed capital into a
portfolio of high-growth technology and healthcare businesses. The proceeds of
the Offer will be used to further expand this portfolio and support existing
portfolio companies in accordance with the Company's investment policy.
Availability of Prospectus A copy of the Prospectus has been submitted to the
National Storage Mechanism and will shortly be available for inspection. The
Prospectus is also available to view on the Company's website at:
www.praeturainvestments.co.uk
(https://url.uk.m.mimecastprotect.com/s/RVs4CWYVfNEJoJfKigFo5m-e?domain=praeturainvestments.co.uk)
.
For further information, please contact:
Emily Thompson Praetura Ventures Limited Level 8 Bauhaus, 27 Quay Street
Manchester, M3 3GY Tel: 0161 641 9475
Marc Proudfoot Howard Kennedy Corporate Services LLP No.1 London Bridge
London, SE1 9BG
Important Information
This announcement is an advertisement and not a prospectus. Investors should
not subscribe for or purchase any transferable securities referred to in this
announcement except on the basis of information in the Prospectus published by
Praetura Growth VCT plc.
The value of shares in the Company, and the income from them, may go down as
well as up and investors may not get back the full amount invested. Tax
reliefs available depend on individual circumstances and may change. Past
performance is not a reliable indicator of future results.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PDIBXBDDBBGDGUD
Copyright 2019 Regulatory News Service, all rights reserved